Lack of relevant data |
1 |
Lack of high-quality local clinical data, where such data are critical to the decision |
80 |
21% |
3 |
Insufficient data to conduct study from chosen perspective |
57 |
9% |
5 |
Absence of locally relevant health state preference data suitable for estimating QALYs or DALYs |
43 |
7% |
Lack of commonly accepted standard or methods |
2 |
Poor reporting |
67 |
21% |
4 |
A lack of commonly accepted standards for economic evaluation that is relevant to the LMIC for which the analysis is undertaken |
57 |
19% |
Inappropriate use of methods |
6 |
Inappropriate choice of comparator(s) |
29 |
7% |
7 |
No budget constraints or thresholds considered |
26 |
5% |
8 |
Generalisability not discussed |
14 |
3% |
10 |
Equity and/or gender implications not considered |
12 |
0% |
11 |
No incremental analysis |
11 |
1% |
12 |
No, or inappropriate, sensitivity analysis |
10 |
0% |
13 |
All impacts implied by the chosen perspective not investigated |
10 |
3% |
15 |
Time horizon too short to capture relevant costs and health effects |
9 |
1% |
Inappropriate use of data |
9 |
Clinical data not based on systematic review or primary clinical data not compared with similar studies done elsewhere |
12 |
1% |
14 |
Uncritical use of charges for cost data |
9 |
1% |